Chimeric mice with humanized liver: tools for the study of drug metabolism, excretion, and toxicity.

Stephen C. Strom, Julio Davila, Markus Grompe

Research output: Contribution to journalArticle

95 Citations (Scopus)

Abstract

Recent developments in animal models have allowed the creation of mice with genetic alterations that cause hepatocyte damage that results, over time, in the loss of native hepatocytes. If donor, human hepatocytes are transplanted into these animals, they repopulate the host liver, frequently replacing over 70% of the native liver with human cells. Immunodeficient mice that overexpress urokinase-type plasminogen activator (uPA) and, alternatively, with a knockout of the fumarylacetoacetate hydrolase (Fah) genes are the two most common mouse models for these studies. These mice are called chimeric or "humanized" because the liver is now partially repopulated with human cells. In this report we will review the published work with respect to Phase I and Phase II metabolic pathways and the expression of hepatic transport proteins. While the studies are still at the descriptive stage, it is already clear that some humanized mice display high levels of repopulation with human hepatocytes, express basal and inducible human CYP450 genes, and human conjugation and hepatic transport pathways. When the strengths and weaknesses of these humanized mouse models are fully understood, they will likely be quite valuable for investigations of human liver-mediated metabolism and excretion of drugs and xenobiotics, drug-drug interactions, and for short- and long-term investigation of the toxicity of drugs or chemicals with significant human exposure.

Original languageEnglish (US)
Pages (from-to)491-509
Number of pages19
JournalMethods in molecular biology (Clifton, N.J.)
Volume640
DOIs
StatePublished - 2010
Externally publishedYes

Fingerprint

Liver
Pharmaceutical Preparations
Hepatocytes
Urokinase-Type Plasminogen Activator
Xenobiotics
Metabolic Networks and Pathways
Drug-Related Side Effects and Adverse Reactions
Drug Interactions
Genes
Carrier Proteins
Animal Models

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Chimeric mice with humanized liver : tools for the study of drug metabolism, excretion, and toxicity. / Strom, Stephen C.; Davila, Julio; Grompe, Markus.

In: Methods in molecular biology (Clifton, N.J.), Vol. 640, 2010, p. 491-509.

Research output: Contribution to journalArticle

@article{519649d9383b496a87ea6bbfb93b8ecd,
title = "Chimeric mice with humanized liver: tools for the study of drug metabolism, excretion, and toxicity.",
abstract = "Recent developments in animal models have allowed the creation of mice with genetic alterations that cause hepatocyte damage that results, over time, in the loss of native hepatocytes. If donor, human hepatocytes are transplanted into these animals, they repopulate the host liver, frequently replacing over 70{\%} of the native liver with human cells. Immunodeficient mice that overexpress urokinase-type plasminogen activator (uPA) and, alternatively, with a knockout of the fumarylacetoacetate hydrolase (Fah) genes are the two most common mouse models for these studies. These mice are called chimeric or {"}humanized{"} because the liver is now partially repopulated with human cells. In this report we will review the published work with respect to Phase I and Phase II metabolic pathways and the expression of hepatic transport proteins. While the studies are still at the descriptive stage, it is already clear that some humanized mice display high levels of repopulation with human hepatocytes, express basal and inducible human CYP450 genes, and human conjugation and hepatic transport pathways. When the strengths and weaknesses of these humanized mouse models are fully understood, they will likely be quite valuable for investigations of human liver-mediated metabolism and excretion of drugs and xenobiotics, drug-drug interactions, and for short- and long-term investigation of the toxicity of drugs or chemicals with significant human exposure.",
author = "Strom, {Stephen C.} and Julio Davila and Markus Grompe",
year = "2010",
doi = "10.1007/978-1-60761-688-7_27",
language = "English (US)",
volume = "640",
pages = "491--509",
journal = "Methods in molecular biology (Clifton, N.J.)",
issn = "1064-3745",
publisher = "Humana Press",

}

TY - JOUR

T1 - Chimeric mice with humanized liver

T2 - tools for the study of drug metabolism, excretion, and toxicity.

AU - Strom, Stephen C.

AU - Davila, Julio

AU - Grompe, Markus

PY - 2010

Y1 - 2010

N2 - Recent developments in animal models have allowed the creation of mice with genetic alterations that cause hepatocyte damage that results, over time, in the loss of native hepatocytes. If donor, human hepatocytes are transplanted into these animals, they repopulate the host liver, frequently replacing over 70% of the native liver with human cells. Immunodeficient mice that overexpress urokinase-type plasminogen activator (uPA) and, alternatively, with a knockout of the fumarylacetoacetate hydrolase (Fah) genes are the two most common mouse models for these studies. These mice are called chimeric or "humanized" because the liver is now partially repopulated with human cells. In this report we will review the published work with respect to Phase I and Phase II metabolic pathways and the expression of hepatic transport proteins. While the studies are still at the descriptive stage, it is already clear that some humanized mice display high levels of repopulation with human hepatocytes, express basal and inducible human CYP450 genes, and human conjugation and hepatic transport pathways. When the strengths and weaknesses of these humanized mouse models are fully understood, they will likely be quite valuable for investigations of human liver-mediated metabolism and excretion of drugs and xenobiotics, drug-drug interactions, and for short- and long-term investigation of the toxicity of drugs or chemicals with significant human exposure.

AB - Recent developments in animal models have allowed the creation of mice with genetic alterations that cause hepatocyte damage that results, over time, in the loss of native hepatocytes. If donor, human hepatocytes are transplanted into these animals, they repopulate the host liver, frequently replacing over 70% of the native liver with human cells. Immunodeficient mice that overexpress urokinase-type plasminogen activator (uPA) and, alternatively, with a knockout of the fumarylacetoacetate hydrolase (Fah) genes are the two most common mouse models for these studies. These mice are called chimeric or "humanized" because the liver is now partially repopulated with human cells. In this report we will review the published work with respect to Phase I and Phase II metabolic pathways and the expression of hepatic transport proteins. While the studies are still at the descriptive stage, it is already clear that some humanized mice display high levels of repopulation with human hepatocytes, express basal and inducible human CYP450 genes, and human conjugation and hepatic transport pathways. When the strengths and weaknesses of these humanized mouse models are fully understood, they will likely be quite valuable for investigations of human liver-mediated metabolism and excretion of drugs and xenobiotics, drug-drug interactions, and for short- and long-term investigation of the toxicity of drugs or chemicals with significant human exposure.

UR - http://www.scopus.com/inward/record.url?scp=78049374383&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78049374383&partnerID=8YFLogxK

U2 - 10.1007/978-1-60761-688-7_27

DO - 10.1007/978-1-60761-688-7_27

M3 - Article

C2 - 20645070

AN - SCOPUS:78049374383

VL - 640

SP - 491

EP - 509

JO - Methods in molecular biology (Clifton, N.J.)

JF - Methods in molecular biology (Clifton, N.J.)

SN - 1064-3745

ER -